http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#Head http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#provenance http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/CL_0000136 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/UBERON_0001135 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-diseases/adipocyte%20lipolysis http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/serum%20insulin http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.w3.org/2000/01/rdf-schema#label a(SCHEM:"serum insulin") -| path(SDIS:"adipocyte lipolysis") http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_3 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_2 http://www.w3.org/ns/prov#value Inhibition of PI3-kinase activity using a dominant negative mutant (30), or pharmacological agents such as wortmannin or LY294002 (31), abolishes insulin stimulated glucose uptake and inhibits GLUT4 vesicle translocation to the plasma membrane. Many other cellular effects of insulin, such as antilipolysis, activation of fatty acid synthesis, acetyl CoA-carboxylase, glycogen synthase, Akt phosphorylation, glycogen synthase kinase 3b inactivation, and stimulation of protein synthesis and DNA synthesis, are also inhibited by PI3- kinase suppression PIP3, rather than PIP2, is the major mediator of PI3- kinase dependent biological actions of insulin http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_2 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/10194465 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_3 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/10194465 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#_2 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://purl.org/dc/terms/created 2014-07-03T14:31:29.861+02:00 http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAkxPmq36HcuridK07-ZoO0JR0nR-1aPKswEO9Ikg6VlQ http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234